The future of skincare lies not in singular solutions, but in understanding and supporting the intricate biological processes that maintain skin health from within
Only 10-15% rests in telogen, waiting to shed and make room for new growth
How can I transition a patient from Zepbound (tirzepatide) to retatrutide, specifying the washout period, starting dose, titration schedule, monitoring (weight, fasting glucose/HbA1c, blood pressure, renal function, gastrointestinal side effects) and contraindications (medullary thyroid carcinoma, multiple endocrine neoplasia type 2)?
Monitoring and Biomarker Targets During a MOTS-C Protocol A MOTS-c dosage protocol without biomarker monitoring is an incomplete intervention
Traditional diet and exercise alone produce variable results, with long term success rates below 10% for significant weight loss maintenance